Dashboard
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.29 times
Poor long term growth as Net Sales has grown by an annual rate of 1.37% and Operating profit at -23.61% over the last 5 years
With a growth in Operating Profit of 25.15%, the company declared Very Positive results in Dec 25
Technical trend is Sideways signifying no clear price momentum
With ROCE of 6.9, it has a Attractive valuation with a 1.7 Enterprise value to Capital Employed
Majority shareholders : Promoters
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 132 Cr (Micro Cap)
36.00
42
1.10%
0.24
2.45%
1.74
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Sep-17-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemcrux Enterprises Ltd is Rated Hold by MarketsMOJO
Chemcrux Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 May 2026, providing investors with the most up-to-date view of its performance and prospects.
Read More
Chemcrux Enterprises Ltd is Rated Sell
Chemcrux Enterprises Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read More Announcements 
Compliances-Reg.24(A)-Annual Secretarial Compliance
25-May-2026 | Source : BSEAnnual Secretarial Compliance Report for the year ended 31st March 2026
Board Meeting Intimation for Audited Financial Statements And Results For The Quarter And Year Ended 31St March 2026 Recommendation Of Final Dividend If Any And Any Other Business Or Agenda.
07-May-2026 | Source : BSEChemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve 1. Audited Financial Statements and Results for the quarter and year ended 31st March 2026 and other related matters thereto. 2. Recommendation of Final Dividend for the F.Y. 2025-26 if any; subject to members approval at the ensuing AGM. 3. Any other business or agenda.
Corporate Action-Board to consider Dividend
07-May-2026 | Source : BSEThe meeting of Board of Directors is scheduled to be held on Thursday 14th May 2026 at 11:30 A.M. at Registered Office of the Company to consider the recommendation of Final Dividend if any for the F.Y. 2025-26 subject to members approval at the ensuing AGM.
Corporate Actions 
No Upcoming Board Meetings
Chemcrux Enterprises Ltd has declared 10% dividend, ex-date: 17 Sep 25
No Splits history available
Chemcrux Enterprises Ltd has announced 2:1 bonus issue, ex-date: 06 Sep 21
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Sanjay Marathe (36.46%)
Namita Bhandare (1.49%)
25.83%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is 13.85% vs -10.96% in Dec 2024
YoY Growth in quarter ended Dec 2025 is 19.70% vs -50.38% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -1.75% vs -8.55% in Sep 2024
Growth in half year ended Sep 2025 is -87.03% vs -33.05% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 3.83% vs -9.43% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -49.06% vs -40.45% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -10.78% vs -17.53% in Mar 2024
YoY Growth in year ended Mar 2025 is -53.67% vs -41.23% in Mar 2024